Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder
Public ClinicalTrials.gov record NCT00235508. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Efficacy of Eszopiclone 3 mg as Adjunctive Therapy in Subjects With Insomnia Related to Generalized Anxiety Disorder.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine the safety and efficacy of eszopiclone as adjunctive therapy in the treatment of insomnia in patients with insomnia related to Generalized Anxiety Disorder. All subjects will receive an approved anxiolytic agent and will be randomized to nightly therapy with either eszopiclone or placebo.
Study identification
- NCT ID
- NCT00235508
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 420 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2005 (Type not available)
- Primary completion
- Apr 2006 (Actual)
- Completion
- Apr 2006 (Actual)
- Last update posted
- Feb 22, 2012
2005 – 2006
United States locations
- U.S. sites
- 64
- U.S. states
- 25
- U.S. cities
- 64
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Scottsdale | Arizona | — | — |
| Not listed | Irvine | California | — | — |
| Not listed | La Mesa | California | — | — |
| Not listed | National City | California | — | — |
| Not listed | Oceanside | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | Pasadena | California | — | — |
| Not listed | Redlands | California | — | — |
| Not listed | Riverside | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Farmington | Connecticut | — | — |
| Not listed | Washington D.C. | District of Columbia | — | — |
| Not listed | Coral Springs | Florida | — | — |
| Not listed | Fort Lauderdale | Florida | — | — |
| Not listed | Gainesville | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Smyrna | Georgia | — | — |
| Not listed | Northfield | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Owensboro | Kentucky | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Rockville | Maryland | — | — |
| Not listed | Braintree | Massachusetts | — | — |
| Not listed | Brighton | Massachusetts | — | — |
| Not listed | Brockton | Massachusetts | — | — |
| Not listed | Cambridge | Massachusetts | — | — |
| Not listed | Watertown | Massachusetts | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Kenilworth | New Jersey | — | — |
| Not listed | Piscataway | New Jersey | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Lawrence | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Durham | North Carolina | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Bismarck | North Dakota | — | — |
| Not listed | Beachwood | Ohio | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Middleburg Heights | Ohio | — | — |
| Not listed | Eugene | Oregon | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Salem | Oregon | — | — |
| Not listed | Moon Township | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Scotland | Pennsylvania | — | — |
| Not listed | Columbia | South Carolina | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Richardson | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Wichita Falls | Texas | — | — |
| Not listed | Falls Church | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Middleton | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00235508, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2012 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00235508 live on ClinicalTrials.gov.